Reliability and validity of ICARS in focal cerebellar lesions

Movement Disorders

Volumn 22, Issue 15, 2007, Pages 2162-2169

  Schoch, Beate ^a   Regel, Jens Peter ^a   Frings, Markus ^a   Gerwig, Marcus ^a   Maschke, Matthias ^a,b   Neuhäuser, Markus ^a,c   Timmann, Dagmar ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

^c RheinAhrCampus ^*  (Germany)

Author keywords

Cerebellar lesion; ICARS; Principal component analysis; Reliability; Validity

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CEREBELLAR ATAXIA; CEREBELLUM INJURY; CHILD; CONSTRUCT VALIDITY; CONTROLLED STUDY; CRONBACH ALPHA COEFFICIENT; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INTERNAL CONSISTENCY; MAJOR CLINICAL STUDY; MALE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ATAXIA; CEREBELLAR DISEASES; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 38049059927     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21543     Document Type: Article

References (30)

1. Trouillas P, Takayanagi T, Hallett M, et al. International Cooperative Ataxia Rating scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 1997;145:205-211.
2. Artuch R, Aracil A, Mas A, et al. Friedreich's ataxia: idebenone treatment in early stage patients. Neuropediatrics 2002;33:190-193.
3. Gabsi S, Gouider-Khouja N, Belal S, et al. Effect of vitamin E supplementation in patients with ataxia with vitamin E deficiency. Eur J Neurol 2001;8:477-481.
4. Mori M, Adachi Y, Mori N, et al. Double-blind crossover study of branched-chain amino acid therapy in patients with spinocerebellar degeneration. J Neurol Sci 2002;195:149-152.
5. Yabe I, Sasaki H, Yamashita I, Takei A, Tashiro K. Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating scale and body stabilometry. Acta Neurol Scand 2001;104: 44-47.
6. Cano SJ, Hobart JC, Hart PE, Korlipara LV, Schapira AH, Cooper JM. International Cooperative Ataxia Rating scale (ICARS): appropriate for studies of Friedreich's ataxia? Mov Disord 2005;20:1585-1591.
7. Schmitz-Hübsch T, Tezenas du Montcel S, Baliko L, et al. Reliability and validity of the International Cooperative Ataxia Rating scale: a study in 156 spinocerebellar ataxia patients. Mov Disord 2006;21:699-704.
8. Storey E, Tuck K, Hester R, Hughes A, Churchyard A. Inter-rater reliability of the International Cooperative Ataxia Rating scale (ICARS). Mov Disord 2004;19:190-192.
9. Tison F, Yekhlef F, Balestre E, et al. Application of the International Cooperative Ataxia scale rating in multiple system atrophy. Mov Disord 2002;17:1248-1254.
10. Mahoney FI, Barthel DW. Functional evaluation: The Barthel index. MD State Med J 1965;14:61-65.
11. Schmitz-Hubsch T, du Montcel ST, Baliko L, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology 2006;66:1717-1720.
12. Frings M, Maschke M, Gerwig M, Diener HC, Timmann D. Acquisition of simple auditory and visual sequences in cerebellar patients. Cerebellum 2006;5:206-211.
13. Gerwig M, Dimitrova A, Kolb FP, et al. Comparison of eyeblink conditioning in patients with superior and posterior inferior cerebellar lesions. Brain 2003;126 (Part 1):71-94.
14. Gerwig M, Haerter K, Hajjar K, et al. Trace eyeblink conditioning in human subjects with cerebellar lesions. Exp Brain Res 2006; 170:7-21.
15. Gerwig M, Hajjar K, Dimitrova A, et al. Timing of conditioned eyeblink responses is impaired in cerebellar patients. J Neurosci 2005;25:3919-3931.
16. Maschke M, Drepper J, Burgerhoff K, et al. Differences in trace and delay visuomotor associative learning in cerebellar patients. Exp Brain Res 2002;147:538-548.
17. Maschke M, Schugens M, Kindsvater K, et al. Fear conditioned changes of heart rate in patients with medial cerebellar lesions. J Neurol Neurosurg Psychiatry 2002;72:116-118.
18. Ozimek A, Richter S, Hein-Kropp C, et al. Cerebellar mutism-report of four cases. J Neurol 2004;251:963-972.
19. Richter S, Kaiser O, Hein-Kropp C, et al. Preserved verb generation in patients with cerebellar atrophy. Neuropsychologia 2004; 42:1235-1246.
20. Richter S, Schoch B, Kaiser O, et al. Behavioral and affective changes in children and adolescents with chronic cerebellar lesions. Neurosci Lett 2005;381:102-107.
21. Richter S, Schoch B, Kaiser O, et al. Children and adolescents with chronic cerebellar lesions show no clinically relevant signs of aphasia or neglect. J Neurophysiol 2005;94:4108-4120.
22. Richter S, Schoch B, Ozimek A, et al. Incidence of dysarthria in children with cerebellar tumors: a prospective study. Brain Lang 2005;92:153-167.
23. Schoch B, Gorissen B, Richter S, et al. Do children with focal cerebellar lesions show deficits in shifting attention? J Neurophysiol 2004;92:1856-1866.
24. Timmann D, Gerwig M, Frings M, Maschke M, Kolb FP. Eyeblink conditioning in patients with hereditary ataxia: a one-year follow-up study. Exp Brain Res 2005;162:332-345.
25. Cochrane DD, Gustavsson B, Poskitt KP, Steinbok P, Kestle JR. The surgical and natural morbidity of aggressive resection for posterior fossa tumors in childhood. Pediatr Neurosurg 1994;20: 19-29.
26. Kase CS, Norrving B, Levine SR, et al. Cerebellar infarction. Clinical and anatomic observations in 66 cases. Stroke 1993;24: 76-83.
27. Kelly PJ, Stein J, Shafqat S, et al. Functional recovery after rehabilitation for cerebellar stroke. Stroke 2001;32:530-534.
28. Klockgether T, Ludtke R, Kramer B, et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain 1998;121 (Part 4):589-600.
29. Schols L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004;3:291-304.
30. Keith RA, Granger CV, Hamilton BB, Sherwin FS. The functional independence measure: a new tool for rehabilitation. Adv Clin Rehabil 1987;1:6-18.